Biogen Inc. (LON:0R1B)
London · Delayed Price · Currency is GBP · Price in USD 128.53
-1.27 (-0.98%)
At close: Aug 11, 2025
Catalent Market Cap
Biogen has a market cap or net worth of 14.00 billion as of August 12, 2025. Its market cap has decreased by -45.56% in one year.
Market Cap
14.00B
Enterprise Value
16.86B
Revenue
7.30B
Ranking
n/a
PE Ratio
12.53
Stock Price
$128.53
Market Cap Chart
Since September 17, 1991, Biogen's market cap has increased from 89.21M to 14.00B, an increase of 15,588.99%. That is a compound annual growth rate of 16.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 14.00B | -21.37% |
| Dec 31, 2024 | 17.80B | -39.53% |
| Dec 29, 2023 | 29.44B | -11.06% |
| Dec 30, 2022 | 33.10B | 27.16% |
| Dec 31, 2021 | 26.03B | -5.69% |
| Dec 31, 2020 | 27.60B | -31.73% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 169.37B |
| GSK plc | 56.29B |
| Haleon | 31.89B |
| Smith & Nephew | 11.72B |
| ConvaTec Group | 4.68B |
| Hikma Pharmaceuticals | 3.85B |
| Oxford Nanopore Technologies | 2.07B |
| HUTCHMED (China) | 1.93B |